VYNEVYNE Therapeutics Inc.
28.56USD+12.22%Mkt Cap: 19.07M $P/E: —28d ago
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a t…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap19.07M $
Enterprise Value-5.88M $
Revenue (TTM)454.00K $
Gross Profit454.00K $
Net Income (TTM)-21.72M $
Revenue/Share0.5300 USD
Last Price28.56 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.35
PEG—
EV/EBITDA0.24
EV/Revenue-12.94
P/S42.00
P/B0.77
EPS (TTM)-27.58
EPS (Forward)-82.50
52W Range
14.0522% of range79.75
52W High79.75 USD
52W Low14.05 USD
Profitability
Gross Margin100.00%
Oper. Margin-4437.21%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-63.16%
ROA-37.01%
Growth
Revenue Growth-57.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.74M $
CapEx (TTM)—
FCF Margin-4493.39%
FCF Yield-106.98%
Net Debt-24.93M $
Net Debt/EBITDA1.02
Balance Sheet
Debt/Equity—
Current Ratio20.86
Quick Ratio20.17
Book Value/Sh36.93 USD
Cash/Share37.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJul 22, 2026
Pay Date—
Splits
Last Split1:50
Split DateJul 27, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.667.70K
Float613.69K
Insiders17.93%
Institutions39.62%
Short Interest
Short Ratio0.1d
Short % Float0.56%
Short % Out.0.55%
Shares Short3.68K
Short (prev mo.)2.20K
Technical
SMA 5034.03 (-16.1%)
SMA 20028.60 (-0.1%)
Beta2.01
S&P 52W Chg18.16%
Avg Vol (30d)30.01K
Avg Vol (10d)47.29K
Technical Indicators
RSI (14)39.6
MACD0.7222
MACD Signal1.4038
MACD Hist.-0.6816
BB Upper46.22 USD
BB Middle35.53 USD
BB Lower24.83 USD
BB Width60.20%
ATR (14)4.086 USD
Vol Ratio (20d)2.39x